PMGC Holdings Completes 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing
ELAB is trading near its 52-week low of $3.968 (12% above the low).
Summary
PMGC Holdings Inc. has completed its previously announced 1-for-6 reverse stock split, effective March 10, 2026, to maintain its Nasdaq listing.
Key Events · Corporate Governance and Compliance · ELAB
-
Reverse Stock Split Effective
The company's 1-for-6 reverse stock split became effective on March 10, 2026, with common stock trading on a split-adjusted basis on Nasdaq.
-
Authorized Shares Adjusted
Post-split, the company's authorized capital stock is 583,333,334 shares, comprising 83,333,334 common shares and 500,000,000 preferred shares.
-
Equity Instruments Adjusted
Outstanding stock awards, options, and warrants, along with their exercise prices, were proportionally adjusted to reflect the split.
Analysis · ELAB · Life Sciences
This 8-K formally announces the effectiveness of the 1-for-6 reverse stock split, which began trading on a split-adjusted basis on March 10, 2026. While the split was previously anticipated, its completion is a significant corporate governance action often undertaken by companies to meet exchange listing requirements and improve stock perception. For a nano-cap company like PMGC Holdings, maintaining its Nasdaq listing is crucial for investor visibility and access to capital. The split also proportionally adjusts outstanding equity awards and warrants.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1996 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ELAB was trading at $4.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.9M. The 52-week trading range was $3.97 to $686.28. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.